# Study to Determine the Effects Treatment With Amlexanox 0.5% Oral Rinse Solution on Oral Mucositis Associated With Radiation Therapy for Cancer of the Head and Neck Region

> **NCT01083875** · PHASE2 · COMPLETED · sponsor: **Access Pharmaceuticals, Inc.** · enrollment: 58 (actual)

## Conditions studied

- Oral Mucositis

## Interventions

- **DRUG:** amlexanox
- **DRUG:** Vehicle rinse

## Key facts

- **NCT ID:** NCT01083875
- **Lead sponsor:** Access Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-02
- **Primary completion:** —
- **Final completion:** 2001-06
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2010-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01083875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01083875, "Study to Determine the Effects Treatment With Amlexanox 0.5% Oral Rinse Solution on Oral Mucositis Associated With Radiation Therapy for Cancer of the Head and Neck Region". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01083875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*